Mind Immune Therapeutics
Biotechnology, 7 Greenhouse Rd, Kingston, Rhode Island, 02881, United States, 1-10 Employees
Phone Number: +14*********
Who is MINDIMMUNE THERAPEUTICS
MindImmune is a pre-clinical stage company focused on neuro-inflammation, targeting Alzheimer's disease (AD) as initial clinical indication. The company's lead program is an antibody-base...
Read More
-
Headquarters: 7 Greenhouse Rd, Kingston, Rhode Island, 02881, United States
-
Date Founded: 2016
-
Employees: 1-10
-
Revenue: $1 Billion and Over
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from MINDIMMUNE THERAPEUTICS
MindImmune Therapeutics Org Chart and Mapping
Email
Phone
Similar Companies to MindImmune Therapeutics
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding MindImmune Therapeutics
Answer: MindImmune Therapeutics's headquarters are located at 7 Greenhouse Rd, Kingston, Rhode Island, 02881, United States
Answer: MindImmune Therapeutics's phone number is +14*********
Answer: MindImmune Therapeutics's official website is https://mindimmune.com
Answer: MindImmune Therapeutics's revenue is $1 Billion and Over
Answer: MindImmune Therapeutics's SIC: 2834
Answer: MindImmune Therapeutics's NAICS: 325412
Answer: MindImmune Therapeutics has 1-10 employees
Answer: MindImmune Therapeutics is in Biotechnology
Answer: MindImmune Therapeutics contact info: Phone number: +14********* Website: https://mindimmune.com
Answer: MindImmune is a pre-clinical stage company focused on neuro-inflammation, targeting Alzheimer's disease (AD) as initial clinical indication. The company's lead program is an antibody-based therapeutic, aiming to inhibit an innate immune response originating in the periphery which is triggered by AD pathology. The lead program is in late stage pre-clinical development, contemplating IND filing near-term. If successful in clinical development, the company's therapeutic strategy would represent a fundamental breakthrough for the AD field. MindImmune scientists are at the forefront in recognizing the therapeutic opportunities in targeting the immune system to treat brain disease. MindImmune is based in Kingston, RI and is building an affiliation with the George & Anne Ryan Institute for Neuroscience at the University of Rhode Island to leverage the rapidly expanding Rhode Island ecosystem of academic neurosciences resources to advance its drug development programs.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month